About the Product

Description


Risplom 3 Tablet contains Risperidone 3mg, an atypical antipsychotic widely used for managing schizophrenia, bipolar disorder, and irritability associated with autism. It helps control psychotic symptoms, mood swings, and aggression effectively.

Risperidone works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, stabilizing brain neurotransmission for better symptom management with reduced side effects.

Tablet form ensures accurate dosing, patient-friendly administration, and better adherence. Its strong clinical acceptance keeps it in steady demand in mental health clinics, hospitals, and pharmacies.

Adding Risplom 3 Tablet to your neuropsychiatric and antipsychotic portfolio strengthens your product range with a trusted, high-rotation therapy. Its prescriber confidence, patient preference, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

Common side effects may include drowsiness, dizziness, weight gain, increased appetite, nausea, or dry mouth. Rare but serious side effects include movement disorders (extrapyramidal symptoms), tardive dyskinesia, neuroleptic malignant syndrome, or severe allergic reactions. Immediate medical attention should be sought if serious symptoms occur.

Risplom 3 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (manic or mixed episodes), and irritability associated with autism spectrum disorders, as prescribed by a healthcare professional.

Risplom 3 Tablet should be taken exactly as prescribed. Avoid abrupt discontinuation, as it may worsen symptoms. Caution is advised in patients with heart disease, seizure disorders, or liver/kidney impairments. Inform the doctor of all other medications being taken.

Store Risplom 3 Tablet in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions